Chlorothiazide/methyldopa

(3S)-4-(7-chloro-1-methyl-pyrazolo[4,3-b]pyridin-5-yl)-3-methyl-morpholine:hydrochloride.

(5-chloro-6-methoxy-3-pyridyl)methanol.

(5-chloro-6-methoxy-3-pyridyl)methanol.

(5-chloro-6-methoxy-3-pyridyl)methanol.

(6S)-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrimidine-6-carboxylate.

(R)-(+)-7,7''-Bis[di(4-methylphenyl)phosphino]-2,2'',3,3''-tetrahydro-1,1''-spirobiindane.

A potent, cell-permeable inhibitor of SET7/9 (IC₅₀ = 2 nM) that demonstrates greater than 1,000-fold selectivity over a panel of 18 other methyltransferases.

A potent, cell-permeable inhibitor of SET7/9 (IC₅₀ = 2 nM) that demonstrates greater than 1,000-fold selectivity over a panel of 18 other methyltransferases.

A potent, cell-permeable inhibitor of SET7/9 (IC₅₀ = 2 nM) that demonstrates greater than 1,000-fold selectivity over a panel of 18 other methyltransferases.

Description(R,R)-2,2′-Bipyrrolidine L-tartrate trihydrate can be used to prepare the ligand (+)-(2R,2′R)- 1,1′-bis(2-pyridylmethyl)-2,2′-bipyrrolidine, which in turn can be used to synthesize its iron complexes applicable in C-N bond formation

Description(R,R)-2,2′-Bipyrrolidine L-tartrate trihydrate can be used to prepare the ligand (+)-(2R,2′R)- 1,1′-bis(2-pyridylmethyl)-2,2′-bipyrrolidine, which in turn can be used to synthesize its iron complexes applicable in C-N bond formation

(TBUXPHOS)PD(P-CH3C6H4(CL)